Senate Bill 2733

AN ACT TO CREATE THE MISSISSIPPI WHOLESALE PRESCRIPTION DRUG IMPORTATION PROGRAM; TO PROVIDE THAT THE DIVISION OF MEDICAID SHALL ESTABLISH THE PROGRAM TO PROVIDE PRESCRIPTION DRUGS AVAILABLE OUTSIDE OF THE UNITED STATES TO CONSUMERS IN THE STATE AT A LOWER COST; TO REQUIRE THE DIVISION TO CONTRACT WITH ONE OR MORE PRESCRIPTION DRUG WHOLESALERS AND CANADIAN SUPPLIERS TO IMPORT PRESCRIPTION DRUGS; TO REQUIRE THE DIVISION TO DEVELOP A REGISTRATION PROCESS FOR HEALTH BENEFIT PLANS; TO REQUIRE PROVIDERS AND PHARMACIES TO OBTAIN AND DISPENSE SUCH DRUGS; TO REQUIRE THE DIVISION TO COMPLY WITH CERTAIN FEDERAL LAWS REGULATING SUCH PROGRAMS; TO PROVIDE THAT A PRESCRIPTION DRUG MAY BE IMPORTED INTO THE STATE ONLY IF THE DRUG MEETS F.D.A. STANDARDS AND DOES NOT VIOLATE FEDERAL PATENT LAWS, AMONG OTHER REQUIREMENTS; TO REQUIRE THE DIVISION TO MONITOR ANY POTENTIAL ANTICOMPETITIVE ACTIVITIES AFFECTED BY THE PROGRAM; TO AUTHORIZE THE DIVISION TO IMPOSE A FEE ON EACH PRESCRIPTION DRUG SOLD UNDER THE PROGRAM; TO REQUIRE THE DIRECTOR OF THE DIVISION TO DEVELOP AUDITING PROCEDURES; TO REQUIRE THE DIVISION TO SUBMIT A REPORT ON THE PROGRAM TO THE LEGISLATURE AND GOVERNOR EACH YEAR; TO CREATE NEW SECTION 73-21-158, MISSISSIPPI CODE OF 1972, TO REQUIRE EACH DRUG MANUFACTURER TO SUBMIT A QUARTERLY REPORT TO THE COMMISSIONER OF THE DEPARTMENT OF INSURANCE WITH THE CURRENT WHOLESALE ACQUISITION COST INFORMATION FOR THE PRESCRIPTION DRUGS SOLD IN THE STATE BY THAT MANUFACTURER; TO SET CERTAIN OTHER REPORTING REQUIREMENTS, INCLUDING THE NAME OF THE DRUG AND AGGREGATE REBATE AMOUNTS; TO REQUIRE PHARMACY BENEFIT MANAGERS PROVIDING SERVICES FOR A HEALTH CARE PLAN AND EACH HEALTH INSURER TO SUBMIT CERTAIN REPORTS TO THE COMMISSIONER; AND FOR RELATED PURPOSES.

In the Senate

• Brice Wiggins

  Sponsor

l9n doesn't hold this bill's text yet.

In the Senate Feb 19 – Mar 12

1. Feb 19Referred to the Senate committee on Medicaid
2. Mar 5Reported from committee in the Senate: title sufficient, do pass as a committee substitute
3. Mar 12Committee substitute adopted in the Senate
4. Passed the Senate

In the House of Representatives Mar 13 – Apr 2

1. Mar 13Sent to the House
2. Mar 18Referred to the House committees on Medicaid and on Accountability, Efficiency, Transparency
3. Apr 2Died in committee in the House